This has been found in both type 1 and type 2 diabetes and, in addition to reductions in glucose levels following treatment with insulin and other glucose-lowering drugs, it has also been reported after diet or bariatric surgery, thus supporting the concept that the velocity of blood glucose reduction is more important than any particular glucose-lowering strategy. This evidence concerns the gene INS and type 2 diabetes mellitus.